Allyx Therapeutics
New Haven, United States· Est. 2020
Develops novel therapeutics targeting synaptic dysfunction in neurodegenerative diseases.
Private Company
Total funding raised: $12M
About
Develops novel therapeutics targeting synaptic dysfunction in neurodegenerative diseases.
Small Molecules
Funding History
1Total raised:$12M
Seed$12MJun 15, 2022